Skip to main content
L

Not yet reviewed: this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

Glaucine

This article is a stubmissing:
Subjective Effects
Interactions
Tolerance
Legality
Glaucine molecule structureGlaucine molecule structure

Glaucine is an aporphine alkaloid found in several plant species, including members of the Papaveraceae family.1 It is used medically to suppress coughing in some countries1 and has airway-widening and anti-inflammatory effects.1 Its psychoactive effects can include sedation2 and hallucinations characterised by colourful visual images. Reported side effects also include fatigue.1

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Threshold~50 mg
Light50-100 mg
Moderate100-150 mg
Strong150-200 mg
Heavy200+ mg

Duration

Onset45-90 minutes
After Effects1-8 hours
Total6-8 hours

Subjective Effects

Subjective Effects not written up yet

Pharmacology

Pharmacodynamics

Glaucine blocks L-type calcium channels at the benzothiazepine binding site, reducing calcium entry and promoting relaxation of bronchial smooth muscle without affecting intracellular calcium stores. It also selectively inhibits PDE4 noncompetitively in human bronchial tissue and granulocytes3, although its potency is very low. Glaucine antagonizes dopamine receptors, with a preference for D1 and D1-like receptors, and inhibits monoamine oxidase enzymes. Both enantiomers antagonize α1 adrenergic receptors4, while their serotonergic actions differ: (S)-glaucine shows partial agonism at 5-HT2 receptor subtypes4, and (R)-glaucine positively modulates 5-HT2 receptors, including 5-HT2A. Toll-like receptors also contribute to its anti-inflammatory action.

Pharmacokinetics

An oral tablet formulation of glaucine has a reported half-life of 6-8 hours.

Metabolitesnone documented yet

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check TripSit

Tolerance

Tolerance not written up yet

Harm Potential

Addiction & Dependence

Psychological

Low

Classified as habit-forming, though detailed characterization of psychological addiction potential is limited.

Psychosis Risk

Moderate

Produces hallucinogenic effects characterized by bright and colorful visual images. Users may feel detached and perceive themselves as being 'in another world' while remaining oriented to their environment but unable to take clear and adequate action. These dissociative-type symptoms appear to be a common feature of the drug's effects rather than rare adverse reactions.

History & Culture

Glaucine was used medically as a cough suppressant in Iceland, Romania, Bulgaria, Russia, and other eastern European countries. The Bulgarian pharmaceutical company Sopharma marketed it in tablet form.6…

Legality

Legality not written up yet

References

Citations

  1. Herbal Drugs of Abuse: Glaucium flavum and Sceletium tortuosum: Metabolism and toxicological detectability of their alkaloids glaucine, mesembrine and mesembrenone. Universität des Saarlandes (2014). https://d-nb.info/1064305768/341234
  2. Schedule II Drugs and Commercial Motor Vehicle Driver Safety. Federal Motor Carrier Safety Administration (2006). https://www.fmcsa.dot.gov/sites/fmcsa.dot.gov/files/docs/Final_Schedule_II_Drugs_Evidence_Report.pdf1
  3. Bronchodilator and anti-inflammatory activities of glaucine: In vitro studies in human airway smooth muscle and polymorphonuclear leukocytes. British Journal of Pharmacology (1999). https://doi.org/10.1038/sj.bjp.07027021
  4. In vitro functional evaluation of isolaureline, dicentrine and glaucine enantiomers at 5-HT2 and α1 receptors. Chemical Biology & Drug Design (2019). https://doi.org/10.1111/cbdd.13390123
  5. Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel. PubMed (1992). https://doi.org/10.1111/j.1476-5381.1992.tb14345.x1
  6. ГЛАУВЕНТ, інструкція, застосування препарату ГЛАУВЕНТ. МОЗ — Нормативна база (2010). https://mozdocs.kiev.ua/likiview.php?id=265261
  7. Cardiovascular Toxicity Associated with Recreational Use of Diphenylprolinol (diphenyl-2-pyrrolidinemethanol [D2PM]). Journal of Medical Toxicology (2008). https://doi.org/10.1007/bf031611951
  8. Detection of the pharmaceutical agent glaucine as a recreational drug. European Journal of Clinical Pharmacology (2008). https://doi.org/10.1007/s00228-007-0451-91

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed: this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the Glaucine article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.